Lisa Rydén
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Oncology top 1%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 71
- Cancer Genomics and Diagnostics 15
- Oncology 56
- Cancer Cells and Metastasis 18
- HER2/EGFR in Cancer Research 17
- Cancer survivorship and care 9
- Co-authors
- Pär‐Ola Bendahl (70 shared papers)Mårten Fernö (50 shared papers)Karin Jirström (25 shared papers)Göran Landberg (20 shared papers)Dorthe Grabau (26 shared papers)Kristina Aaltonen (20 shared papers)Olle Stål (26 shared papers)Lao H. Saal (24 shared papers)
- Journals
- Breast Cancer Research and Treatment (17 papers)BMC Cancer (16 papers)Cancer Research (15 papers)PLoS ONE (8 papers)Breast Cancer Research (7 papers)
- Partner nations
- SwedenUnited StatesDenmark
In The Last Decade
Lisa Rydén
177 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 131
- Cancer Research 2.4k
- Oncology 2.0k
- Molecular Biology 1.8k
- Pulmonary and Respiratory Medicine 767
- Genetics 586
Countries citing papers authored by Lisa Rydén
This map shows the geographic impact of Lisa Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Rydén more than expected).
Fields of papers citing papers by Lisa Rydén
This network shows the impact of papers produced by Lisa Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Rydén. The network helps show where Lisa Rydén may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa Rydén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 188 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 357 | |
| 2 | 2013 | 189 | |
| 3 | 2015 | 147 | |
| 4 | 2004 | 136 | |
| 5 | 2018 | 130 | |
| 6 | 2016 | 128 | |
| 7 | 2012 | 125 | |
| 8 | 2014 | 122 | |
| 9 | 2015 | 118 | |
| 10 | 2019 | 115 | |
| 11 | 2006 | 111 | |
| 12 | 2017 | 110 | |
| 13 | 2005 | 108 | |
| 14 | 2006 | 107 | |
| 15 | 2003 | 106 | |
| 16 | 2005 | 98 | |
| 17 | 2013 | 97 | |
| 18 | 2018 | 92 | |
| 19 | 2006 | 91 | |
| 20 | 2004 | 85 |
About Lisa Rydén
Lisa Rydén is a scholar working on Cancer Research, Oncology, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 188 papers that have together received 5.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (71 papers), Cancer Cells and Metastasis (18 papers), HER2/EGFR in Cancer Research (17 papers), Estrogen and related hormone effects (15 papers), Cancer Genomics and Diagnostics (15 papers), Advanced Breast Cancer Therapies (11 papers), Cancer survivorship and care (9 papers) and Breast Lesions and Carcinomas (9 papers). The work is most often cited by research in Cancer Research (2.4k citations), Oncology (2.0k citations), Molecular Biology (1.8k citations), Pulmonary and Respiratory Medicine (767 citations) and Genetics (586 citations). Lisa Rydén has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Pär‐Ola Bendahl, Mårten Fernö, Karin Jirström, Göran Landberg, Dorthe Grabau, Kristina Aaltonen, Olle Stål, Lao H. Saal, Bo Nordenskjöld and Åke Borg. Their work appears in journals such as Breast Cancer Research and Treatment, BMC Cancer, Cancer Research, PLoS ONE and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.